5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18473282 | ERBB/BTK INHIBITORS | SCHMIDT, IZABELA MARIA | 1621 | Non-Final OA | Sep 25, 2023 |
| 18066275 | PYRAZINE COMPOUNDS AND USES THEREOF | WILLIS, DOUGLAS M | 1624 | Non-Final OA | Dec 14, 2022 |
| 17885578 | ERBB RECEPTOR INHIBITORS | HIRAKIS, SOPHIA P | 1623 | Final Rejection | Aug 11, 2022 |
| 17788730 | NOVEL ANTI-FGFR2B ANTIBODIES | BELYAVSKYI, MICHAIL A | 1644 | Final Rejection | Jun 23, 2022 |
| 17788729 | NOVEL ANTI-FGFR2B ANTIBODIES | SANG, HONG | 1646 | Non-Final OA | Jun 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial